Dr.Evidence® Appoints Ken Kobayashi, MD, FACP to its Medical Strategy Advisory Board

Ken Kobayashi, MD, FACP, accomplished oncologist, clinical pharmacologist, and senior global life sciences executive, joins the Medical Strategy Advisory Board (“MSAB”), expanding its expertise in drug developmentSANTA MONICA, Calif.--(BUSINESS WIRE)--Dr.Evidence is pleased to announce the appointment of Ken Kobayas...

Related Keywords

United States ,Northwestern University Medical School ,Illinois ,Japan ,Chicago ,America ,David Tovey ,Calum Macrae ,Daiichi Sankyo ,Josepha Boystak ,Frank Rockhold ,Rose Higgins ,Ken Kobayashi ,Michael Klag ,Washington University ,National Cancer Institute ,Astrazeneca ,Pfizer ,Drug Administration ,Novartis ,Medical Strategy Advisory Board ,Latin America ,